Curis Inc (CRIS) Stock Price, Quote & News

Latest News on CRIS

Apr 2, 2025, 4:05 PM EDT - 1 day ago

Curis to Present at Upcoming Healthcare Conference in April

Mar 31, 2025, 9:59 AM EDT - 4 days ago

Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 8:00 AM EDT - 4 days ago

Curis Provides Fourth Quarter 2024 Business Update

Mar 28, 2025, 4:07 PM EDT - 6 days ago

Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025

Dec 10, 2024, 8:00 AM EST - 4 months ago

Curis Announces Additional Data from TakeAim Leukemia Study

Nov 14, 2024, 11:02 AM EST - 5 months ago

Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 8:00 AM EST - 5 months ago

Curis Provides Third Quarter 2024 Business Update

Nov 7, 2024, 8:00 AM EST - 5 months ago

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Oct 29, 2024, 6:04 AM EDT - 5 months ago

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Sep 23, 2024, 8:30 AM EDT - 6 months ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 17, 2024, 7:30 AM EDT - 7 months ago

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 4, 2024, 8:00 AM EDT - 7 months ago

Curis to Present at Upcoming Healthcare Conferences in September

Aug 1, 2024, 3:44 PM EDT - 8 months ago

Curis, Inc. (CRIS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 8:00 AM EDT - 8 months ago

Curis Provides Second Quarter 2024 Financial and Operating Update

Jul 25, 2024, 8:00 AM EDT - 9 months ago

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Jul 10, 2024, 7:30 AM EDT - 9 months ago

Curis to Present at Upcoming Healthcare Conference in July

Jul 8, 2024, 7:30 AM EDT - 9 months ago

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

May 10, 2024, 8:00 AM EDT - 11 months ago

Curis to Present Updated Data from the TakeAim Leukemia Study

May 7, 2024, 8:08 PM EDT - 11 months ago

Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript

May 7, 2024, 8:00 AM EDT - 11 months ago

Curis Provides First Quarter 2024 Business Update

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conferences in April

Feb 8, 2024, 2:04 PM EST - 1 year ago

Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript

Feb 8, 2024, 8:00 AM EST - 1 year ago

Curis Provides Fourth Quarter 2023 Business Update

Feb 1, 2024, 8:00 AM EST - 1 year ago

Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024

Dec 12, 2023, 8:00 AM EST - 1 year ago

Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

Dec 11, 2023, 8:00 AM EST - 1 year ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

Dec 6, 2023, 8:00 AM EST - 1 year ago

Curis Announces Three Presentations at ASH

Dec 5, 2023, 8:00 AM EST - 1 year ago

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

Nov 17, 2023, 9:04 AM EST - 1 year ago

Curis's stock rises as analysts see ‘the next Pharmacyclics'

Nov 2, 2023, 2:32 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 8:00 AM EDT - 1 year ago

Curis Provides Third Quarter 2023 Business Update

Oct 26, 2023, 8:30 AM EDT - 1 year ago

Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023

Sep 12, 2023, 8:00 AM EDT - 1 year ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Aug 3, 2023, 9:35 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 4:01 PM EDT - 1 year ago

Curis Provides Second Quarter 2023 Business Update

Jul 27, 2023, 6:25 PM EDT - 1 year ago

Curis to Release Second Quarter 2023 Financial Results and Hold Conference Call on August 3, 2023

Jul 6, 2023, 8:01 AM EDT - 1 year ago

FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID

Jul 6, 2023, 8:00 AM EDT - 1 year ago

Curis Announces $15.1 Million Registered Direct Offering

May 4, 2023, 9:59 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q1 2023 Earnings Call Transcript

May 4, 2023, 4:01 PM EDT - 2 years ago

Curis Provides First Quarter 2023 Business Update

Apr 27, 2023, 4:01 PM EDT - 2 years ago

Curis to Release First Quarter 2023 Financial Results and Hold Conference Call on May 4, 2023

Mar 13, 2023, 12:22 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q4 2022 Earnings Call Transcript

Mar 13, 2023, 8:00 AM EDT - 2 years ago

Curis Provides Fourth Quarter 2022 Business Update

Mar 8, 2023, 7:09 PM EST - 2 years ago

Curis Reschedules Fourth Quarter 2022 Business Update and Conference Call

Mar 2, 2023, 4:01 PM EST - 2 years ago

Curis to Release Fourth Quarter 2022 Financial Results and Hold Conference Call on March 9, 2023

Dec 12, 2022, 10:00 AM EST - 2 years ago

Curis Announces Additional Encouraging Clinical Data from TakeAim Leukemia Study of emavusertib (CA-4948) in Monotherapy R/R AML and hrMDS

Dec 5, 2022, 11:08 PM EST - 2 years ago

Curis to Host Webcast to Discuss Updated Emavusertib Clinical Data in Leukemia

Nov 9, 2022, 7:36 PM EST - 2 years ago

Market Cap	12.39M
Revenue (ttm)	10.02M
Net Income (ttm)	-47.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-473.15%
Debt to Equity Ratio	0.00

Volume	63,433
Avg Vol	41,290
Day's Range	N/A - N/A
Shares Out	8.49M
Stochastic %K	0%
Beta	3.51
Analysts	Strong Sell
Price Target	$21.00